145 related articles for article (PubMed ID: 38533785)
1. Gut motility and hormone changes after bariatric procedures.
Gala K; Ghusn W; Abu Dayyeh BK
Curr Opin Endocrinol Diabetes Obes; 2024 Jun; 31(3):131-137. PubMed ID: 38533785
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on appetite, circulating acyl-ghrelin, peptide YY3-36 and active GLP-1 levels in non-diabetic humans.
Yousseif A; Emmanuel J; Karra E; Millet Q; Elkalaawy M; Jenkinson AD; Hashemi M; Adamo M; Finer N; Fiennes AG; Withers DJ; Batterham RL
Obes Surg; 2014 Feb; 24(2):241-52. PubMed ID: 23996294
[TBL] [Abstract][Full Text] [Related]
3. Effect of laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy on fasting gastrointestinal and pancreatic peptide hormones: A prospective nonrandomized trial.
Yang J; Gao Z; Williams DB; Wang C; Lee S; Zhou X; Qiu P
Surg Obes Relat Dis; 2018 Oct; 14(10):1521-1529. PubMed ID: 30449509
[TBL] [Abstract][Full Text] [Related]
4. Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones.
Nannipieri M; Baldi S; Mari A; Colligiani D; Guarino D; Camastra S; Barsotti E; Berta R; Moriconi D; Bellini R; Anselmino M; Ferrannini E
J Clin Endocrinol Metab; 2013 Nov; 98(11):4391-9. PubMed ID: 24057293
[TBL] [Abstract][Full Text] [Related]
5. Are the Changes in Gastrointestinal Hormone Secretion Necessary for the Success of Bariatric Surgery? A Critical Review of the Literature.
Lampropoulos C; Alexandrides T; Tsochatzis S; Kehagias D; Kehagias I
Obes Surg; 2021 Oct; 31(10):4575-4584. PubMed ID: 34304379
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal hormones and weight loss response after Roux-en-Y gastric bypass.
de Hollanda A; Jiménez A; Corcelles R; Lacy AM; Patrascioiu I; Vidal J
Surg Obes Relat Dis; 2014; 10(5):814-9. PubMed ID: 24969090
[TBL] [Abstract][Full Text] [Related]
7. Changes in GI hormones and their effect on gastric emptying and transit times after Roux-en-Y gastric bypass in rat model.
Suzuki S; Ramos EJ; Goncalves CG; Chen C; Meguid MM
Surgery; 2005 Aug; 138(2):283-90. PubMed ID: 16153438
[TBL] [Abstract][Full Text] [Related]
8. Preoperative assessment of gut hormones does not correlate to weight loss after Roux-en-Y gastric bypass surgery.
Werling M; Fändriks L; Vincent RP; Cross GF; le Roux CW; Olbers T
Surg Obes Relat Dis; 2014; 10(5):822-8. PubMed ID: 25282191
[TBL] [Abstract][Full Text] [Related]
9. Distinct adaptations of endocrine and cognitive functions may contribute to high variability in long-term weight loss outcome after bariatric surgery.
Lammert M; Medawar E; Hartmann H; Grasser L; Dietrich A; Fenske W; Horstmann A
Physiol Behav; 2023 Oct; 269():114279. PubMed ID: 37356514
[TBL] [Abstract][Full Text] [Related]
10. Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial.
Peterli R; Steinert RE; Woelnerhanssen B; Peters T; Christoffel-Courtin C; Gass M; Kern B; von Fluee M; Beglinger C
Obes Surg; 2012 May; 22(5):740-8. PubMed ID: 22354457
[TBL] [Abstract][Full Text] [Related]
11. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters.
le Roux CW; Aylwin SJ; Batterham RL; Borg CM; Coyle F; Prasad V; Shurey S; Ghatei MA; Patel AG; Bloom SR
Ann Surg; 2006 Jan; 243(1):108-14. PubMed ID: 16371744
[TBL] [Abstract][Full Text] [Related]
12. Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass surgery.
Beckman LM; Beckman TR; Sibley SD; Thomas W; Ikramuddin S; Kellogg TA; Ghatei MA; Bloom SR; le Roux CW; Earthman CP
JPEN J Parenter Enteral Nutr; 2011 Mar; 35(2):169-80. PubMed ID: 21378246
[TBL] [Abstract][Full Text] [Related]
13. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects.
Jacobsen SH; Olesen SC; Dirksen C; Jørgensen NB; Bojsen-Møller KN; Kielgast U; Worm D; Almdal T; Naver LS; Hvolris LE; Rehfeld JF; Wulff BS; Clausen TR; Hansen DL; Holst JJ; Madsbad S
Obes Surg; 2012 Jul; 22(7):1084-96. PubMed ID: 22359255
[TBL] [Abstract][Full Text] [Related]
14. Diet and gastrointestinal bypass-induced weight loss: the roles of ghrelin and peptide YY.
Chandarana K; Gelegen C; Karra E; Choudhury AI; Drew ME; Fauveau V; Viollet B; Andreelli F; Withers DJ; Batterham RL
Diabetes; 2011 Mar; 60(3):810-8. PubMed ID: 21292870
[TBL] [Abstract][Full Text] [Related]
15. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism.
Rubino F; Gagner M; Gentileschi P; Kini S; Fukuyama S; Feng J; Diamond E
Ann Surg; 2004 Aug; 240(2):236-42. PubMed ID: 15273546
[TBL] [Abstract][Full Text] [Related]
16. Gut and Metabolic Hormones Changes After Endoscopic Sleeve Gastroplasty (ESG) Vs. Laparoscopic Sleeve Gastrectomy (LSG).
Lopez-Nava G; Negi A; Bautista-Castaño I; Rubio MA; Asokkumar R
Obes Surg; 2020 Jul; 30(7):2642-2651. PubMed ID: 32193741
[TBL] [Abstract][Full Text] [Related]
17. Ghrelin, leptin, and glycemic control after sleeve gastrectomy versus Roux-en-Y gastric bypass-results of a randomized clinical trial.
Kalinowski P; Paluszkiewicz R; Wróblewski T; Remiszewski P; Grodzicki M; Bartoszewicz Z; Krawczyk M
Surg Obes Relat Dis; 2017 Feb; 13(2):181-188. PubMed ID: 27692906
[TBL] [Abstract][Full Text] [Related]
18. Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.
Steinert RE; Feinle-Bisset C; Asarian L; Horowitz M; Beglinger C; Geary N
Physiol Rev; 2017 Jan; 97(1):411-463. PubMed ID: 28003328
[TBL] [Abstract][Full Text] [Related]
19. Changes in postprandial gut hormones after metabolic surgery: a comparison of gastric bypass and sleeve gastrectomy.
Lee WJ; Chen CY; Chong K; Lee YC; Chen SC; Lee SD
Surg Obes Relat Dis; 2011; 7(6):683-90. PubMed ID: 21996600
[TBL] [Abstract][Full Text] [Related]
20. Effect of Roux-en-Y gastric bypass on the distribution and hormone expression of small-intestinal enteroendocrine cells in obese patients with type 2 diabetes.
Rhee NA; Wahlgren CD; Pedersen J; Mortensen B; Langholz E; Wandall EP; Friis SU; Vilmann P; Paulsen SJ; Kristiansen VB; Jelsing J; Dalbøge LS; Poulsen SS; Holst JJ; Vilsbøll T; Knop FK
Diabetologia; 2015 Oct; 58(10):2254-8. PubMed ID: 26186884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
